Search the Newsreel

Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

On July 29, AbCellera Biologics Inc. (NASDAQ:ABCL) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced a strategic collaboration to research, develop, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases. Under the agreement, AbCellera will leverage its proprietary TCE platform to lead discovery, while Vertex will …

Babcock & Wilcox (BW) director Philip Moeller buys 5,000 shares at $9.50

Babcock & Wilcox Enterprises, Inc. director Philip D. Moeller purchased 5,000 common shares at $9.50 per share on August 13, 2026, in an open market transaction. This transaction increased his direct holdings to 240,809 common shares. The filing indicates that this purchase was not …

AXT, T1 Energy and Babcock & Wilcox Soaring Higher On Friday

Quick Read AXTI surged on optical sector momentum and 165% YoY revenue growth; TE jumped 10% as new US solar tariffs protect its domestic manufacturing plans. BW landed a 20-turbine Siemens data center deal and drew a 7.66M share Ameriprise disclosure, but still trades …

Cencora (COR): Leveraging Healthcare Growth and AI-Driven Productivity

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% …

AbCellera Biologics Stock 6-Day Winning Spree: Stock Climbs 85%

6 Green Days In A Row: AbCellera Biologics Stock Is Up 85%

AbCellera Biologics (ABCL) stock has surged 85% over six consecutive trading days, reaching a new 52-week high and adding $1.5 billion to its market value. While its revenue growth is strong at 101.3% over the last twelve months, the company faces profitability challenges with …

5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call

5 Insightful Analyst Questions From Cencora's Q2 Earnings Call Cencora's second quarter was marked by performance that met Wall Street's expectations on revenue and exceeded consensus on non-GAAP profitability, driving a positive market response. Management credited execution in specialty pharmaceuticals, especially through its Management …

BW|Babcock & Wilcox Enterprises Inc|Price:9.350|Chg%:-0.420

Babcock & Wilcox Enterprises Inc (BW) stock is currently trading at $10.325, up 10.43% today. The company, which provides renewable, environmental, and thermal technologies, has a market cap of $1.50 billion and a 52-week high of $22.03 and a low of $0.68. Analysts currently …

AbCellera Biologics Inc. • Robinhood Token (ABCL) Price Prediction for 2026 to 2031

This article provides price predictions for AbCellera Biologics Inc. • Robinhood Token (ABCL) from 2026 to 2045, based on Bybit AI's analysis of user-driven Consensus Ratings and historical patterns. It forecasts a positive trend for ABCL's price, with significant potential ROI over the years, …

Need To Know: Analysts Are Much More Bullish On Babcock & Wilcox Enterprises, Inc. (NYSE:BW) Revenues

BW Stock Edges Higher Overnight: Babcock & Wilcox Signs Agreement With Siemens Energy On 20 Steam Turbines

AbCellera Biologics prices oversubscribed $200M offering at $9.75/share

AbCellera Biologics (ABCL [https://seekingalpha.com/symbol/ABCL]) announced the pricing of its oversubscribed underwritten public offering [https://seekingalpha.com/pr/20617674-abcellera-announces-pricing-of-oversubscribed-200-million-public-offering-of-common-shares] of 17.44M common shares at $9.75 per share. In lieu of common shares, AbCellera is also offering pre-funded warrants to purchase up to 3.08M common shares at $9.74999 per warrant …

AbCellera (ABCL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Chief Legal and Compliance Officer - Tryn Stimart President and Chief Executive Officer - Carl L. Hansen Chief Financial Officer - Andrew Booth Full Conference Call Transcript Operator: …

Cencora bestätigt Prognose trotz Volumenverlust bei Walgreens

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - Here's Why

Cencora (COR) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations and Enterprise Productivity - Bennett Murphy President and Chief Executive Officer - Robert Mauch Executive Vice President and Chief Financial Officer - Eva …

AbCellera Biologics Inc. (NASDAQ:ABCL) Given Consensus Recommendation of "Moderate Buy" by Analysts

AbCellera Biologics Inc. (NASDAQ:ABCL) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $12.83, notably boosted by Truist Financial's increased target of $30. The company's shares have rallied significantly following positive Phase 2 results for its experimental …

Revenue Downgrade: Here's What Analysts Forecast For AbCellera Biologics Inc. (NASDAQ:ABCL)

Analysts have recently downgraded their revenue forecasts for AbCellera Biologics Inc. for 2024 and 2025, suggesting a more cautious outlook on the company's near-term growth prospects. Despite the revised estimates, the average price target for ABCL stock remains unchanged, implying that analysts see potential …

ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL)

Babcock And Wilcox (BW) Stock Looks Cheap On Sales As Risks Linger

Babcock & Wilcox Stock Surges 42% After Hours: Here's What Investors Need To Know

AbCellera Biologics (ABCL) Stock Sees Fair Value Lift After Clinical Data And Jazz Deal

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The latest analyst update on AbCellera Biologics reflects a higher Fair Value estimate of …

AbCellera Biologics (ABCL) On ABCL635 Trial Results And A Richer Valuation Story

Babcock & Wilcox Enterprises (BW) Returns To Profit, Is It Still A Bargain?

Babcock & Wilcox (BW) Stock Rebounds As Backlog Surges But Risks Persist

AbCellera stock falls on $200M public offering launch

AbCellera Biologics Inc. (NASDAQ:ABCL) shares dropped 3.7% after the company announced a $200 million underwritten public offering of common stock and pre-funded warrants. The biotechnology company intends to use the net proceeds to fund research, development, and clinical advancement of its internal pipeline, including …

Why Babcock & Wilcox Enterprises Stock Popped Today

Truist Financial Issues Positive Forecast for AbCellera Biologics (NASDAQ:ABCL) Stock Price

AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 8.7% - Here's What Happened

The Biggest Premarket Movers: Babcock & Wilcox and Fermi Soar

Quick Read BW surged 35% on a blowout Q2 earnings beat while FRMI jumped 16% after locking in a $6.5 billion AI campus lease. AMD Instinct GPUs anchor the TensorWave deal, which starts at 222 MW and expands to over 650 MW for large-scale …

Babcock & Wilcox soars on big Q2 beat, signing of data center power agreement

[Stock market data with uptrend vector] sitox Babcock & Wilcox (BW [https://seekingalpha.com/symbol/BW]) up 37.3% pre-market Tuesday after the maker of power generation equipment reported Q2 profit [https://seekingalpha.com/news/4630306-babcock-wilcox-enterprises-gaap-eps-of-007-beats-by-004-revenue-of-3197m-beats-by-12273m] and revenue that easily exceeded analyst consensus, and signed [https://seekingalpha.com/pr/20614127-babcock-and-wilcox-signs-agreement-with-siemens-energy-to-commence-work-on-20-steam-turbines] an agreement with Siemens Energy (SMEGF [https://seekingalpha.com/symbol/SMEGF

Babcock & Wilcox Signs Agreement with Siemens Energy to Commence Work on 20 Steam Turbines for Data Center Power Generation

- Agreement positions B&W to deliver 20 50-megawatt steam turbines for customers on accelerated timelines - AI data centers and large-scale power generation projects driving energy demand AKRON, Ohio, August 11, 2026--(BUSINESS WIRE)--Babcock & Wilcox (B&W) (NYSE: BW) announced today that it has signed …

Babcock & Wilcox Shares Surge 40.5% After Q2 Results Beat Expectations and Guidance Rises